Phase 2 Dose-finding Studies with MCP and Modelling Techniques
In the webinar you will learn about the MCPMod methodology for design and analysis of phase II dose finding studies under model uncertainty.
At the end of the webinar you will be able to:
- Design and analyse dose-response studies using MCP Mod
- Compare a wide choice of candidate models
- Implement a statistical methodology that has been approved by the FDA and EMA as fit-for-purpose (FFP)
Pantelis Vlachos, Principal, Strategic Consulting, Cytel
Before joining Cytel, Pantelis Vlachos was a Principal Biostatistician for Merck Serono in Geneva, and taught statistics at Carnegie Mellon University for 12 years. His research focus is adaptive designs, but mainly from a Bayesian perspective. Pantelis is a key contributor to the continuing development and training in the use of the East software package. Pantelis also has served on editorial boards of several scientific journals and online archives, including Managing Editor of “Bayesian Analysis” journal.